Fund HoldingsACUTA CAPITAL PARTNERS, LLC

Total Portfolio Value
$99.40M
Total Bought
$19.52M
Total Sold
$42.56M
Net Transaction
-$23.04M
Filing Period:
Securities
SharesValue ($K)
Q3 2024
Q4 2024
Change
Q3 2024
Q4 2024
Weight (%)
Change
BRIGHT MINDS BIOSCIENCES INC069,124+69,12402,4902.50%+2,490
TREVI THERAPEUTICS INC(TRVI)290,500771,958+481,4589703,1803.20%+2,210
AADI BIOSCIENCES INC1,849,4021,849,40203,8105,8355.87%+2,025
PRAXIS PRECISION MEDICINES I(PRAX)57,50067,500+10,0003,3095,1955.23%+1,886
CIDARA THERAPEUTICS INC054,473+54,47301,4641.47%+1,464
NEWAMSTERDAM PHARMA CO NV
ORDINARY SHARES
050,000+50,00001,2851.29%+1,285
TECTONIC THERAPEUTIC INC13,70033,008+19,3084151,5241.53%+1,109
ARGENX SE(ARGX)5,9006,910+1,0103,1984,2504.28%+1,051
UNICYCIVE THERAPEUTICS INC1,979,1992,303,000+323,8018071,8291.84%+1,022
ZYMEWORKS INC(ZYME)067,240+67,24009840.99%+984
ELEDON PHARMACEUTICALS INC0235,750+235,75009710.98%+971
LIQUIDIA CORPORATION(LQDA)73,500137,709+64,2097351,6191.63%+884
SANGAMO THERAPEUTICS INC(SGMOQ)0740,000+740,00007550.76%+755
EDGEWISE THERAPEUTICS INC(EWTX)63,00087,658+24,6581,6812,3402.35%+659
FORTE BIOSCIENCES INC(FBRX)018,139+18,13904120.41%+412
CORVUS PHARMACEUTICALS INC(CRVS)074,307+74,30703980.40%+398
THIRD HARMONIC BIO INC15,50849,800+34,2922105120.52%+302
VERVE THERAPEUTICS INC146,100160,200+14,1007079040.91%+196
ASCENDIS PHA-ADR(ASND)21,00022,976+1,9763,1363,1633.18%+28
NUVATION BIO INC -CW27(NUVB)90,83290,83209210.02%+12
HELIX ACQUISITION CORP II180,945180,94501,8911,9001.91%+9
REVOLUTION MEDICINES INC(RVMD)108,000111,700+3,7004,8984,8864.92%-12
RAPPORT THERAPEUTICS INC(RAPP)17,60016,400-1,2003602910.29%-70
ARTIVA BIOTHERAPEUTICS INC44,00044,00006804440.45%-236
TRAVERE THERAPEUTICS INC(TVTX)19,0000-19,0002660-266
BENITEC BIOPHARMA INC29,8000-29,8002740-274
CLIMB BIO INC54,0000-54,0002750-275
LEAP THERAPEUTICS INC120,5000-120,5003100-310
CELCUITY INC(CELC)46,60025,000-21,6006953270.33%-368
CORBUS PHARMACEUTICALS HOLDINGS18,5000-18,5003820-382
CRINETICS PHARMACEUTICALS IN(CRNX)131,700122,900-8,8006,7306,2846.32%-446
ULTRAGENYX PHARMACEUTICAL INC(RARE)25,10021,000-4,1001,3948830.89%-511
INSMED INC(INSM)107,500104,800-2,7007,8487,2357.28%-612
MERSANA THERAPEUTICS INC1,200,0001,120,500-79,5002,2681,6021.61%-666
GERON CORP(GERN)154,9000-154,9007030-703
GILEAD SCIENCES INC(GILD)19,5009,150-10,3501,6358450.85%-790
OCULAR THERAPEUTIX INC(OCUL)1,190,0711,111,071-79,00010,3549,4899.55%-865
TOURMALINE BIO INC332,095351,842+19,7478,5387,1357.18%-1,403
ENLIVEN THERAPEUTICS INC296,368267,368-29,0007,5696,0166.05%-1,553
TERNS PHARMACEUTICALS INC487,000447,500-39,5004,0622,4792.49%-1,582
DYNE THERAPEUTICS INC(DYN)46,2000-46,2001,6600-1,660
ACELYRIN INC364,0000-364,0001,7950-1,795
ROCKET PHARMACEUTICALS INC190,000134,500-55,5003,5091,6911.70%-1,819
COMPASS PATHWAYS PLC(CMPS)386,5000-386,5002,4350-2,435
MEREO BIOPHARMA GROUP PL-ADR1,260,700779,308-481,3925,1812,7282.74%-2,454
TAYSHA GENE THERAPIES INC(TSHA)2,118,992884,244-1,234,7484,2591,5301.54%-2,729
KURA ONCOLOGY INC. COMMON STOCK(KURA)197,0000-197,0003,8490-3,849
ARCELLX INC
COMMON STOCK
62,10010,743-51,3575,1868240.83%-4,362
VAXCYTE INC(PCVX)135,40045,000-90,40015,4723,6843.71%-11,788
Page 1 of 1